HUP9802517A2 - Foszfonsavval helyettesített benzazepinon-N-ecetsav-származékok, eljárás ezek előállítására és az e vegyületeket tartalmazó gyógyászati készítmények - Google Patents

Foszfonsavval helyettesített benzazepinon-N-ecetsav-származékok, eljárás ezek előállítására és az e vegyületeket tartalmazó gyógyászati készítmények

Info

Publication number
HUP9802517A2
HUP9802517A2 HU9802517A HUP9802517A HUP9802517A2 HU P9802517 A2 HUP9802517 A2 HU P9802517A2 HU 9802517 A HU9802517 A HU 9802517A HU P9802517 A HUP9802517 A HU P9802517A HU P9802517 A2 HUP9802517 A2 HU P9802517A2
Authority
HU
Hungary
Prior art keywords
benzazepinon
substituted
producing
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU9802517A
Other languages
English (en)
Inventor
Jörg Meil
Dirk Thormählen
Harald Waldeck
Michael Wurl
Original Assignee
Solvay Pharmaceuticals Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh. filed Critical Solvay Pharmaceuticals Gmbh.
Publication of HU9802517D0 publication Critical patent/HU9802517D0/hu
Publication of HUP9802517A2 publication Critical patent/HUP9802517A2/hu
Publication of HUP9802517A3 publication Critical patent/HUP9802517A3/hu
Publication of HU221177B1 publication Critical patent/HU221177B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Az (I) általánős képletű vegyületek (mely képletben R1 jelentése hidrőgénatőm vagy valamely biőlabilis főszfőnsavésztertképező csőpőrt; R2 jelentése hidrőgénatőm vagy valamely biőlabilis főszfőnsavésztertképező csőpőrt; és R3 jelentése hidrőgénatőm vagy valamely biőlabilis karbőnsavésztertképező csőpőrt) és az (I) általánős képletű savak gyógyászatilagalkalmas sói NEP-gátló hatással rendelkeznek. ŕ
HU9802517A 1997-11-12 1998-11-02 Phosphonic acid-substituted benzazepinon-n-acetic acid derivatives, process for producing them and pharmaceutical compositions containing them HU221177B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19750002A DE19750002A1 (de) 1997-11-12 1997-11-12 Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (4)

Publication Number Publication Date
HU9802517D0 HU9802517D0 (en) 1998-12-28
HUP9802517A2 true HUP9802517A2 (hu) 1999-09-28
HUP9802517A3 HUP9802517A3 (en) 2000-06-28
HU221177B1 HU221177B1 (en) 2002-08-28

Family

ID=7848410

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802517A HU221177B1 (en) 1997-11-12 1998-11-02 Phosphonic acid-substituted benzazepinon-n-acetic acid derivatives, process for producing them and pharmaceutical compositions containing them

Country Status (28)

Country Link
US (1) US5952327A (hu)
EP (1) EP0916679B1 (hu)
JP (1) JP4162780B2 (hu)
KR (1) KR19990045100A (hu)
CN (1) CN1187361C (hu)
AR (1) AR009911A1 (hu)
AT (1) ATE228144T1 (hu)
AU (1) AU746907B2 (hu)
BR (1) BR9804582A (hu)
CA (1) CA2253997C (hu)
CZ (1) CZ296123B6 (hu)
DE (2) DE19750002A1 (hu)
DK (1) DK0916679T3 (hu)
DZ (1) DZ2652A1 (hu)
ES (1) ES2186961T3 (hu)
HK (1) HK1019338A1 (hu)
HU (1) HU221177B1 (hu)
ID (1) ID21393A (hu)
IL (1) IL126984A (hu)
NO (1) NO317640B1 (hu)
NZ (1) NZ332744A (hu)
PL (1) PL191436B1 (hu)
PT (1) PT916679E (hu)
RU (1) RU2211219C2 (hu)
SK (1) SK283233B6 (hu)
TR (1) TR199802289A2 (hu)
UA (1) UA60304C2 (hu)
ZA (1) ZA9810316B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03010341A (es) * 2001-05-18 2004-03-10 Solvay Pharm Gmbh Uso de compuestos con actividad inhibitoria de epn/mp combinada en la preparacion de medicamentos.
CA2473447A1 (en) * 2002-01-16 2003-07-24 Solvay Pharmaceuticals B.V. Solid salts of benzazepine compounds and their use in the preparation of pharmaceutical compounds
CL2004000544A1 (es) * 2003-03-18 2005-01-28 Pharmacia Corp Sa Organizada B Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
US7427611B2 (en) * 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7232813B2 (en) * 2004-01-12 2007-06-19 Solvay Pharmaceuticals B.V. Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders
JP4951350B2 (ja) * 2004-01-12 2012-06-13 アボツト・ヘルスケア・プロダクツ・ベー・ブイ 神経変性障害の予防及び処置のための中性エンドペプチダーゼ（ｎｅｐ）及びヒト可溶性エンドペプチダーゼ（ｈｓｅｐ）阻害剤
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
US7816347B2 (en) 2004-12-15 2010-10-19 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
WO2007102171A2 (en) * 2006-03-07 2007-09-13 Panacea Biotec Ltd Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition
US8198341B2 (en) 2008-12-18 2012-06-12 Icl-Ip America Inc. Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
CA2887169C (en) 2012-10-17 2022-01-04 Icl-Ip America Inc. Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
US9528269B2 (en) 2014-06-09 2016-12-27 Johns Manville Roofing systems and roofing boards with non-halogenated fire retardant
US9815256B2 (en) 2014-06-09 2017-11-14 Johns Manville Foam boards including non-halogenated fire retardants
US9523195B2 (en) 2014-06-09 2016-12-20 Johns Manville Wall insulation boards with non-halogenated fire retardant and insulated wall systems
US9815966B2 (en) 2014-07-18 2017-11-14 Johns Manville Spray foams containing non-halogenated fire retardants
CN107383084A (zh) * 2017-06-14 2017-11-24 浙江嘉华化工有限公司 一种0‑乙基磷酸钠的制备方法
PL424453A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors

Also Published As

Publication number Publication date
CZ356298A3 (cs) 1999-06-16
BR9804582A (pt) 2000-05-09
DZ2652A1 (fr) 2003-03-15
EP0916679B1 (de) 2002-11-20
RU2211219C2 (ru) 2003-08-27
DK0916679T3 (da) 2002-12-16
AR009911A1 (es) 2000-05-03
PT916679E (pt) 2003-03-31
HU221177B1 (en) 2002-08-28
HU9802517D0 (en) 1998-12-28
CA2253997C (en) 2009-05-12
ES2186961T3 (es) 2003-05-16
ATE228144T1 (de) 2002-12-15
AU9234498A (en) 2000-06-08
PL329635A1 (en) 1999-05-24
CA2253997A1 (en) 1999-05-12
NO985262L (no) 1999-05-14
CZ296123B6 (cs) 2006-01-11
AU746907B2 (en) 2002-05-02
SK283233B6 (sk) 2003-04-01
DE59806345D1 (de) 2003-01-02
US5952327A (en) 1999-09-14
CN1217334A (zh) 1999-05-26
JPH11292886A (ja) 1999-10-26
IL126984A (en) 2001-07-24
TR199802289A3 (tr) 1999-06-21
HUP9802517A3 (en) 2000-06-28
SK151698A3 (en) 1999-05-07
IL126984A0 (en) 1999-09-22
DE19750002A1 (de) 1999-05-20
NZ332744A (en) 2000-06-23
UA60304C2 (uk) 2003-10-15
JP4162780B2 (ja) 2008-10-08
CN1187361C (zh) 2005-02-02
ZA9810316B (en) 1999-05-18
TR199802289A2 (xx) 1999-06-21
HK1019338A1 (en) 2000-02-03
ID21393A (id) 1999-06-03
NO317640B1 (no) 2004-11-29
PL191436B1 (pl) 2006-05-31
KR19990045100A (ko) 1999-06-25
NO985262D0 (no) 1998-11-11
EP0916679A1 (de) 1999-05-19

Similar Documents

Publication Publication Date Title
HUP9802517A2 (hu) Foszfonsavval helyettesített benzazepinon-N-ecetsav-származékok, eljárás ezek előállítására és az e vegyületeket tartalmazó gyógyászati készítmények
ES8802220A1 (es) Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos.
BG100946A (en) New amino acid derivatives, method for their preparation and pharmaceutical compositions containing them
ES2191412T3 (es) Derivados de aminoacidos que contienen fluor.
MY102866A (en) Amide derivatives.
MX9803004A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
HUP9702345A2 (hu) 3-Hidroxi-piridin-2-karbonsav-amid-észter-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0100865A2 (hu) Meta-azaciklusos csoporttal N-szubsztituált amino-benzoesav-vegyületek és származékaik mint integrin antagonista hatóanyagok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP9900851A2 (hu) Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására
HUP0300386A2 (hu) Új (amino-propil)-metil-foszfinsavak
HUP9903459A2 (hu) Oxa- és tiabiciklo[3.1.0]hexán-karbonsavak, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
DE69810934D1 (de) Ribonukleosid-derivat und verfahren zu seiner herstellung
ATE8401T1 (de) Anthracyclin-glycoside, verfahren zu ihrer herstellung, zwischenprodukte und ihre herstellung und arzneimittel.
ATE111734T1 (de) Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten.
ATE199909T1 (de) Derivate der phosphonsäure, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
MX9708735A (es) Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos.
ATE25679T1 (de) Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung.
DE69710909D1 (de) Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE69330601D1 (de) Serotoninergische ergolin derivate
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
MY113529A (en) New derivatives of imidazole n- benzyldioxole,processes for their preparation, their use as medicaments and pharmaceutical compositions containing them
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees